Results overview: Found 3 records in 0.02 seconds.
Articles, 3 records found
Articles 3 records found  
1.
12 p, 699.5 KB Duration of the acute hepatic encephalopathy episode determines survival in cirrhotic patients / Ventura-Cots, Meritxell (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Carmona, Isabel ; Moreno, Carolina ; Ampuero, Javier ; Simón-Talero, Macarena (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Sanpedro, Francesc (Hospital Universitari Vall d'Hebron) ; Les, Iñigo ; Romero-Gómez, Manuel ; Genescà, Joan (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Episodes of hepatic encephalopathy (HE) have been related to low survival rate. However, the relation between its clinical evolution and mortality has not been assessed. A retrospective analysis of 245 cirrhotic patients admitted for an acute episode of HE (⩾grade 2) or who developed an HE episode after an upper gastrointestinal bleeding (UGIB) event was performed to assess the relation between time in HE and transplant-free survival. [...]
2017 - 10.1177/1756283X17743419
Therapeutic Advances in Gastroenterology, Vol. 11 (november 2017)  
2.
17.3 KB Hepatitis C virus deep sequencing for sub-genotype identification in mixed infections : A real-life experience / del Campo, José A. (Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain) ; Parra-Sánchez, Manuel (UCM Infectious Diseases and Microbiology, Valme University Hospital, Seville, Spain) ; Figueruela, Blanca (UCM Digestive Diseases, Valme University Hospital, Seville, Spain) ; García-Rey, Silvia (UCM Infectious Diseases and Microbiology, Valme University Hospital, Seville, Spain) ; Quer, Josep (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Gregori, Josep (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Bernal, Samuel (UCM Infectious Diseases and Microbiology, Valme University Hospital, Seville, Spain) ; Grande, Lourdes (UCM Digestive Diseases, Valme University Hospital, Seville, Spain) ; Palomares, José C. (UCM Infectious Diseases and Microbiology, Valme University Hospital, Seville, Spain) ; Romero-Gómez, Manuel (Hospital Universitario Virgen del Rocío, Instituto de Investigación Biomédica de Sevilla (IBiS), Seville, Spain) ; Universitat Autònoma de Barcelona
The effectiveness of the new generation of hepatitis C treatments named direct-acting antiviral agents (DAAs) depends on the genotype, subtype, and resistance-associated substitutions present in individual patients. [...]
2018 - 10.1016/j.ijid.2017.12.016
International journal of infectious diseases, Vol. 67 (february 2018) , p. 114-117  
3.
13 p, 347.6 KB Prediction of week 4 virological response in hepatitis C for making decision on triple therapy : the Optim study / Romero-Gómez, Manuel (Hospital de Valme (Sevilla)) ; Turnes, Juan (Complejo Hospitalario de Pontevedra) ; Ampuero, Javier (Hospital de Valme (Sevilla)) ; Oyagüez, Itziar (Pharmacoeconomics & Outcomes Research IBeria (Madrid)) ; Cuenca, Beatriz (Hospital Universitario Infanta Cristina (Madrid)) ; Gonzalez-García, Juan (Hospital Universitario La Paz (Madrid)) ; Muñoz-Molina, Belén (Roche Farma) ; Aguilar, Rocío (Fisevi (Sevilla)) ; Leal, Sandra (Fisevi (Sevilla)) ; Planas Vilà, Ramon (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Garcia-Samaniego, Javier (Hospital Carlos III (Madrid)) ; Diago, Moisés (Consorci Hospital General Universitari (Valencia)) ; Crespo, Javier (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Calleja, Jose Luís (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Casado, Miguel Ángel (Pharmacoeconomics & Outcomes Research IBeria (Madrid)) ; Solà Lamoglia, Ricard (Hospital del Mar (Barcelona, Catalunya))
Background: Virological response to peginterferon + ribavirin (P+R) at week 4 can predict sustained virological response (SVR). While patients with rapid virological response (RVR) do not require triple therapy, patients with a decline <1log10 IU/ml HCVRNA (D1L) should have treatment discontinued due to low SVR rate. [...]
2015 - 10.1371/journal.pone.0122613
PloS one, Vol. 10, No 3 (March 2015) , p. e0122613  

See also: similar author names
1 Romero-Gomez, M
1 Romero-Gómez, M.
4 Romero-Gómez, Manuel
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.